Clinical Trial Update: Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node [NA]

View source ↗

Summary

A clinical trial update about omitting therapeutic lymph node dissection in stage 3 melanoma and observing major pathological response in the index lymph node; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: D.J. (Dirk) Grünhagen | Conditions: Melanoma, Skin | NA | Status: RECRUITING